Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/003220 stock hub

KRX/003220 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/003220is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

218.2B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/003220

In the news

Latest news · KRX/003220

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-0.8

P25 -17.1P50 0.7P75 8.5

ROIC-0.7

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/003220 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

KRW

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	1,283
Enterprise value	KRW 352.4B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7003220001
Last refreshed	2026-05-10
Market cap	KRW 218.2B
Price	KRW 10,180
Price currency	KRW
Rev Per Employee	471,889,882.78x
Sector	Healthcare
Sic	2834
Symbol	krx/003220
Website	https://www.daewonpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.63%
EV Earnings	-255.43x
EV/EBIT	84.54x
EV/EBITDA	12.62x
EV/FCF	28.17x
EV/Sales	0.58x
FCF yield	5.73%
Forward P/E	15.26x
P/B ratio	0.79x
P/S ratio	0.36x
PE Ratio10 Y	37.64x
PE Ratio3 Y	18.35x
PE Ratio5 Y	59.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.58%
EBITDA Margin	4.5%
FCF margin	2.07%
Gross margin	44.83%
Gross Profit	KRW 271.4B
Gross Profit Growth	-5.09%
Gross Profit Growth3 Y	4.79%
Gross Profit Growth5 Y	10.58%
Net Income	KRW -1.4B
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	0.42%
Profit Margin	-0.23%
Profit Per Employee	KRW -1.1M
ROA	0.36
Roa5y	3.37
ROCE	0.88
ROE	-0.79
Roe5y	5.65
ROIC	-0.75
Roic5y	5.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.51%
Cagr15y	7.55%
Cagr1y	-24.26%
Cagr20y	9.89%
Cagr3y	-10.57%
Cagr5y	-7.73%
Div CAGR10	1.78%
Div CAGR3	-5.9%
Div CAGR5	5.18%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth3 Y	-12.07%
FCF Growth5 Y	-1.66%
OCF Growth	40.88%
OCF Growth10 Y	5.06%
OCF Growth3 Y	17.01%
OCF Growth5 Y	11.14%
Revenue Growth	1.22x
Revenue Growth Quarters	1x
Revenue Growth Years	5x
Revenue Growth3 Y	8.13x
Revenue Growth5 Y	14.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.01
Assets	KRW 613.7B
Cash	KRW 76.5B
Current Assets	KRW 256.6B
Current Liabilities	KRW 216.3B
Debt	KRW 202B
Debt EBITDA	KRW 7.42
Debt Equity	KRW 0.74
Debt FCF	KRW 16.15
Equity	KRW 274.6B
Interest Coverage	0.48
Liabilities	KRW 339.1B
Long Term Assets	KRW 357B
Long Term Liabilities	KRW 122.7B
Net Cash	KRW -125.6B
Net Cash By Market Cap	KRW -57.55
Net Debt EBITDA	KRW 4.61
Net Debt Equity	KRW 0.46
Net Debt FCF	KRW 10.03
Tangible Book Value	KRW 229.2B
Tangible Book Value Per Share	KRW 10,695
WACC	1.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.19
Inventory Turnover	3.17
Net Working Capital	KRW 80.9B
Quick ratio	0.72
Working Capital	KRW 40.3B
Working Capital Turnover	KRW 15.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.67%
Dividend Growth	-16.67%
Dividend Growth Years	0%
Dividend per share	KRW 250
Dividend Years	26
Dividend Yield	2.46%
Ex Div Date	2025-12-29
Last Dividend	KRW 250
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-22.46%
1Y total return	-24.25%
200-day SMA	12,113.8
3Y total return	-28.49%
50-day SMA	10,551.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-33.11%
All Time High	29,958.4
All Time High Change	-66.02%
All Time High Date	2020-07-24
All Time Low	1,319.6
All Time Low Change	671.43%
All Time Low Date	2008-10-27
ATR	267.4
Beta	0.27
Beta1y	0.27
Beta2y	0.26
Ch YTD	-14.81
High	10,290
High52	14,700
High52 Date	2025-06-11
High52ch	-30.75%
Low	10,140
Low52	9,670
Low52 Date	2026-04-09
Low52ch	5.27%
Ma50ch	-3.52%
Price vs 200-day SMA	-15.96%
RSI	38.52
RSI Monthly	28.57
RSI Weekly	32.57
Sharpe ratio	-1.45x
Sortino ratio	-1.6
Total Return	1.78%
Tr YTD	-14.81
Tr15y	197.99%
Tr1m	0.2%
Tr1w	-3.42%
Tr3m	-10.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 3.5B
Operating Income Growth	-86.94
Operating Income Growth3 Y	-56.69
Operating Income Growth5 Y	-32.01
Operating margin	0.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,981,336%
Net Borrowing	13,132,649,780
Shares Insiders	38.8%
Shares Institutions	11.63%
Shares Out	21,433,439
Shares Qo Q	0%
Shares Yo Y	0.67%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 12.5B
Average Volume	32,141.3x
Bv Per Share	12,406.7
CAPEX	KRW -29.8B
Ch10y	-33.86
Ch15y	143.1
Ch1m	0.2
Ch1w	-3.42
Ch1y	-25.8
Ch20y	362.9
Ch3m	-10.62
Ch3y	-32.76
Ch5y	-39.04
Ch6m	-21.39
Change	-0.2%
Change From Open	0.1
Close	10,200
Days Gap	-0.29
Depreciation Amortization	23,747,044,000
Dollar Volume	210,390,060
Earnings Date	2026-05-15
EBIT	KRW 3.5B
EBITDA	KRW 27.2B
EPS	KRW -87.38
F Score	3
FCF	KRW 12.5B
FCF EV Yield	3.55x
FCF Per Share	KRW 584
Financing CF	-929,261,240
Fiscal Year End	December
Founded	1,958
Goodwill	5,999,812,000
Income Tax	KRW 4.7B
Investing CF	-11,416,919,120
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2022-03-07
Last Split Type	Forward
Ma150	11,766
Ma150ch	-13.48%
Ma20	10,582.5
Ma20ch	-3.8%
Net CF	30,139,695,020
Next Earnings Date	2026-05-15
Open	10,170
P FCF Ratio	17.44
P OCF Ratio	5.16
Payment Date	2026-04-24
Position In Range	26.67
Ppne	222,902,124,670
Price Date	2026-05-08
Price EBITDA	KRW 8.01
Ptbv Ratio	0.95
Relative Volume	0.64x
Revenue	605,434,719,610x
Tax By Revenue	0.78x
Tax Rate	186.59%
Tr20y	559.33%
Tr6m	-19.74%
Volume	20,667
Z Score	2.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/003220 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.5%

$250 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.2%

0 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2025-12-29

Performance

KRX/003220 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/003220?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.6%

Share of float held by funds and institutions

Insider ownership

+38.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

KRX/003220 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.5

Neutral momentum band

Price vs 200-day MA

-16.0%

50/200-day relationship not available

Beta (5Y)

0.27

Less volatile than the market

Sharpe ratio

-1.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/003220

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/003220 stock rating?

krx/003220 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/003220 analysis?

The full report lives at /stocks/krx/003220/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/003220?

The latest report frames krx/003220 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/003220 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.